Sangamo Therapeutics
SGMO
#10417
Rank
HK$0.24 B
Marketcap
HK$0.58
Share price
0.00%
Change (1 day)
-84.92%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of March 2026 : HK$0.21 Billion

According to Sangamo Therapeutics 's latest financial reports the company has HK$0.21 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$0.16 B-49.92%
2024-12-31HK$0.32 B-48.56%
2023-12-31HK$0.63 B-70.84%
2022-12-31HK$2.16 B-26.12%
2021-12-31HK$2.93 B-40.95%
2020-12-31HK$4.97 B76.14%
2019-12-31HK$2.82 B-9.91%
2018-12-31HK$3.13 B64.83%
2017-12-31HK$1.90 B71.99%
2016-12-31HK$1.10 B-31.77%
2015-12-31HK$1.61 B16.7%
2014-12-31HK$1.38 B92.87%
2013-12-31HK$0.71 B46.11%
2012-12-31HK$0.49 B-24.62%
2011-12-31HK$0.65 B39.28%
2010-12-31HK$0.46 B-28.77%
2009-12-31HK$0.65 B31.46%
2008-12-31HK$0.50 B-20.76%
2007-12-31HK$0.63 B50.76%
2006-12-31HK$0.41 B15.19%
2005-12-31HK$0.36 B40.85%
2004-12-31HK$0.25 B-23.96%
2003-12-31HK$0.33 B-16.4%
2002-12-31HK$0.40 B-15.33%
2001-12-31HK$0.48 B-3.04%
2000-12-31HK$0.49 B738.94%
1999-12-31HK$59.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$172.88 B 79,835.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$94.37 B 43,538.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$33.57 B 15,424.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
HK$30.19 B 13,859.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$59.92 B 27,606.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$44.70 B 20,569.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$23.59 B 10,808.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$17.42 B 7,956.41%๐Ÿ‡บ๐Ÿ‡ธ USA